JAMIE KELLY: Open Payments
NPI 1891421376 · SHREWSBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 45 payments from 19 companies in 2025. Trend: 2023 $2,135 · 2024 $274 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $83 |
| IMMUNITYBIO, INC. | 5 | $82 |
| Antares Pharma, Inc. | 4 | $75 |
| Boston Scientific Corporation | 3 | $69 |
| PFIZER INC. | 3 | $67 |
| 180 Medical, Inc. | 3 | $67 |
| Janssen Biotech, Inc. | 4 | $58 |
| ACCORD HEALTHCARE, INC. | 3 | $54 |
| Endo USA, Inc. | 2 | $37 |
Products named: GEMTESA, Nubeqa, XTANDI, ANKTIVA, XYOSTED, ERLEADA, Camcevi, AVEED.
Industry payments across NJ — which companies pay providers there.
